These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 31494973)

  • 41. Three-Year Results of Facial Photoaging in Asian Patients After Alexandrite 755 nm Picosecond Laser With Diffractive Lens Array: A Split-Face, Single-Blinded, Randomized Controlled Comparison.
    Yu W; Zhu J; Yu W; Shang Y; Lyu D; Lin X; Xu H; Zhang Z
    Lasers Surg Med; 2021 Oct; 53(8):1065-1072. PubMed ID: 33604905
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and safety of picosecond 755-nm alexandrite laser with diffractive lens array for non-ablative rejuvenation in Chinese skin.
    Wat H; Yee-Nam Shek S; Yeung CK; Chan HH
    Lasers Surg Med; 2019 Jan; 51(1):8-13. PubMed ID: 30152538
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of 577 nm pro-yellow laser in the treatment of melasma: a prospective split-face study.
    Mohamed EM; Younes AH; Hussein GM
    J Cosmet Laser Ther; 2020 Feb; 22(2):107-110. PubMed ID: 32216566
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A randomized, split-face clinical trial of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser versus low-fluence Q-switched alexandrite laser (755 nm) for the treatment of facial melasma.
    Fabi SG; Friedmann DP; Niwa Massaki AB; Goldman MP
    Lasers Surg Med; 2014 Sep; 46(7):531-7. PubMed ID: 24895301
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improved quality of life with effective treatment of facial melasma: the pigment trial.
    Balkrishnan R; Kelly AP; McMichael A; Torok H
    J Drugs Dermatol; 2004; 3(4):377-81. PubMed ID: 15303781
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hydroquinone 4%, tretinoin 0.05%, fluocinolone acetonide 0.01%: a safe and efficacious 12-month treatment for melasma.
    Torok HM; Jones T; Rich P; Smith S; Tschen E
    Cutis; 2005 Jan; 75(1):57-62. PubMed ID: 15732437
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pulsed alexandrite laser for treatment of melasma in Asian patients.
    Cheng CY; Huang YL; Lee MC; Chang SL; Lin YF; Hu S
    J Cosmet Laser Ther; 2017 Aug; 19(4):210-214. PubMed ID: 28151024
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Melasma in Latin America: options for therapy and treatment algorithm.
    Cestari T; Arellano I; Hexsel D; Ortonne JP;
    J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):760-72. PubMed ID: 19646135
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of Picosecond 755-nm Alexandrite Laser With a Diffractive Lens Array on Pore Size Reduction.
    Tran A; Klein R; Robinson D
    J Drugs Dermatol; 2021 Dec; 20(12):1302-1306. PubMed ID: 34898153
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Retrospective Analysis of the Treatment of Melasma Using a Fractional Long-Pulsed Alexandrite Laser in Korean Patients.
    Lee MK; Min KS; Park EJ; Kim KH; Kim KJ
    Dermatol Surg; 2016 Aug; 42(8):952-60. PubMed ID: 27467229
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Randomized, Controlled, Split-Face Study of the Efficacy of a Picosecond Laser in the Treatment of Melasma.
    Lyons AB; Moy RL; Herrmann JL
    J Drugs Dermatol; 2019 Nov; 18(11):1104-1107. PubMed ID: 31741350
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and safety of picosecond laser for the treatment of melasma: a systematic review and meta-analysis.
    Feng J; Shen S; Song X; Xiang W
    Lasers Med Sci; 2023 Mar; 38(1):84. PubMed ID: 36897459
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy and safety of oral tranexamic acid as an adjuvant in Indian patients with melasma: a prospective, interventional, single-centre, triple-blind, randomized, placebo-control, parallel group study.
    Minni K; Poojary S
    J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2636-2644. PubMed ID: 32567734
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative Efficacy Of 35% Glycolic Acid Peel vs. Jessner Peel as an Adjuvant to Topical Triple Combination (2% Hydroquinone, 0.025% Tretinoin, 0.01% Fluocinolone Acetonide) Therapy in Melasma Females Cases.
    Modi A; Parmar S; Marfatiya Y
    J Cosmet Sci; 2021; 72(4):418-431. PubMed ID: 35262482
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Validation of a melasma quality of life questionnaire for Brazilian Portuguese language: the MelasQoL-BP study and improvement of QoL of melasma patients after triple combination therapy.
    Cestari TF; Hexsel D; Viegas ML; Azulay L; Hassun K; Almeida AR; Rêgo VR; Mendes AM; Filho JW; Junqueira H
    Br J Dermatol; 2006 Dec; 156 Suppl 1():13-20. PubMed ID: 17176300
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treating epidermal melasma with a 4% hydroquinone skin care system plus tretinoin cream 0.025%.
    Grimes P; Watson J
    Cutis; 2013 Jan; 91(1):47-54. PubMed ID: 23461059
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and safety of fractional Q-switched 1064-nm neodymium-doped yttrium aluminum garnet laser in the treatment of melasma in Chinese patients.
    Yue B; Yang Q; Xu J; Lu Z
    Lasers Med Sci; 2016 Nov; 31(8):1657-1663. PubMed ID: 27450275
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of the therapeutic efficacy and safety of combined oral tranexamic acid and topical hydroquinone 4% treatment vs. topical hydroquinone 4% alone in melasma: a parallel-group, assessor- and analyst-blinded, randomized controlled trial with a short-term follow-up.
    Lajevardi V; Ghayoumi A; Abedini R; Hosseini H; Goodarzi A; Akbari Z; Hedayat K
    J Cosmet Dermatol; 2017 Jun; 16(2):235-242. PubMed ID: 27762489
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fractional 1064 nm Picosecond Laser in Treatment of Melasma and Skin Rejuvenation in Asians, A Prospective Study.
    Wong CSM; Chan MWM; Shek SYN; Yeung CK; Chan HHL
    Lasers Surg Med; 2021 Oct; 53(8):1032-1042. PubMed ID: 33544930
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 755-nm picosecond laser plus topical 20% azelaic acid compared to topical 20% azelaic acid alone for the treatment of melasma: a randomized, split-face and controlled trial.
    Lai D; Cheng S; Zhou S; Hao J; Chen H; Jia K; Liu H; Cui Y
    Lasers Med Sci; 2024 Apr; 39(1):113. PubMed ID: 38656631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.